Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег Вікторович Крайдашенко, Олег Викторович Крайдашенко, Олександр Євгенович Березін, Александр Евгеньевич БерезинfiledCriticalОлег Вікторович Крайдашенко
Priority to UA94023150ApriorityCriticalpatent/UA15281A/en
Publication of UA15281ApublicationCriticalpatent/UA15281A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to medicine. A method for treatment of chronic coronary heart disease comprises administration of metabolic agents. Glutamic acid, asparcam and pyridoxalphosphate are used as metabolic agents. They are used in such manner: glutamic acid is administered orally at a dose of 1.5 g per a day, asparcam is administered orally at a dose of 1 tablet three times a day and pyridoxalphosphate is administered intramuscular at a dose of 0.01 g per day, and treatment course is 12-14 days.
UA94023150A1994-02-081994-02-08Method for treatment of chronic coronary heart disease
UA15281A
(en)
Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention